Odonate Announces Planned Return of Capital to Stockholders
17 Nov 2021 //
BUSINESSWIRE
Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients
11 Dec 2020 //
BUSINESSWIRE
Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients
11 Dec 2020 //
BUSINESSWIRE